本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Theratechnologies, Inc.

2.52
-0.0500-1.95%
盘后2.550.0300+1.19%19:59 EDT
成交量:77.19万
成交额:199.11万
市值:1.16亿
市盈率:-33.55
高:2.67
开:2.60
低:2.51
收:2.57
数据加载中...
2025/02/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/18

SEC问询函

Form CORRESP - Correspondence
2024/02/21

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/02

SEC问询函

Form CORRESP - Correspondence
2023/11/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/28

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/11/14

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/02/28

年度报告

40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/24

年度报告

40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/25

年度报告

40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2021/02/25

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/15

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]